Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein subunit beta 5 (GNB5) is a regulatory protein that forms part of the heterotrimeric guanine nucleotide-binding (G) protein complex, functioning primarily to mediate and regulate signal transduction initiated by G protein-coupled receptors (GPCRs). It modulates signaling by regulating the GTPase activities of regulators of G protein signaling (RGS) proteins, especially RGS7 and RGS9, which are critical for the termination of G protein signaling in the nervous system, mood and cognition, and heart rate control. Mutations in GNB5 are associated with neurodevelopmental syndromes presenting intellectual disability, developmental delay, and cardiac arrhythmias. No direct pharmacological agents or drugs target GNB5 as of the provided data.
Accelerates GTP hydrolysis on Gα subunits via enhancement of regulator of G protein signaling (RGS) protein activity, promoting inactivation of G protein signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein subunit beta 5 (GNB5).